Black Bird Biotech Statistics
Total Valuation
BBBT has a market cap or net worth of 3,729. The enterprise value is 926,368.
| Market Cap | 3,729 |
| Enterprise Value | 926,368 |
Important Dates
The next estimated earnings date is Wednesday, May 21, 2025.
| Earnings Date | May 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BBBT has 3.73 billion shares outstanding.
| Current Share Class | 3.73B |
| Shares Outstanding | 3.73B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +74.91% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.11 |
| EV / Sales | 25.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -147.15% |
| Return on Invested Capital (ROIC) | -443.35% |
| Return on Capital Employed (ROCE) | 34.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.27 |
| Inventory Turnover | 0.60 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.00% in the last 52 weeks. The beta is 2.86, so BBBT's price volatility has been higher than the market average.
| Beta (5Y) | 2.86 |
| 52-Week Price Change | -99.00% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 26.84 |
| Average Volume (20 Days) | 55,250 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, BBBT had revenue of 36,323 and -836,135 in losses. Loss per share was -0.00.
| Revenue | 36,323 |
| Gross Profit | -13,293 |
| Operating Income | -314,655 |
| Pretax Income | -836,135 |
| Net Income | -836,135 |
| EBITDA | -26,019 |
| EBIT | -314,655 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 5,729 in cash and 928,329 in debt, giving a net cash position of -922,600 or -0.00 per share.
| Cash & Cash Equivalents | 5,729 |
| Total Debt | 928,329 |
| Net Cash | -922,600 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -922,778 |
| Book Value Per Share | -0.00 |
| Working Capital | -927,550 |
Cash Flow
| Operating Cash Flow | -233,056 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -36.60% |
| Operating Margin | -866.27% |
| Pretax Margin | -2,301.94% |
| Profit Margin | n/a |
| EBITDA Margin | -71.63% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BBBT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -156.10% |
| Shareholder Yield | -156.10% |
| Earnings Yield | -22,422.50% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BBBT has an Altman Z-Score of -90.31. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -90.31 |
| Piotroski F-Score | n/a |